Allogeneic hematopoietic cell transplant (Allo-HCT) is a potentially curative therapy for many
malignant and nonmalignant hematological diseases. However, a suitable human leukocyte …

Haploidentical hematopoietic stem cell transplantation (Haplo-SCT) and umbilical cord
blood transplantation (UCBT) are two important alternatives when a matched sibling donor …

Abstract The ongoing coronavirus (COVID-19) pandemic is a global health emergency of
international concern and has affected management plans of many autoimmune disorders …

Graft-versus-host disease (GVHD) prophylaxis based on post-transplant cyclophosphamide
(PTCy) or antithymocyte globulin (ATG) is widely used in allogeneic hematopoietic stem cell …

Allogeneic stem cell transplantation is a cure for patients suffering from thalassemia major
(TM). Historically, patients were limited by the selection of donors, while the advancement of …

Myelodysplastic syndromes are clonal disorders with morphological dysplasia, a variable
degree of cytopenia and a risk of transformation to acute myeloid leukemia. Prognosis is …

Abstract Chronic active Epstein–Barr virus infection (CAEBV) is a subtype of EBV-associated
T/NK cell lymphoproliferative disease and is only curable by allogeneic hematopoietic stem …

Patients with advanced-stage mycosis fungoides (MF) and Sézary syndrome (SS) have a
poor prognosis. Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative …

Epstein-Barr virus-positive T-cell and NK-cell lymphoproliferative diseases (EBV-T/NK-LPD)
is categorized into two major groups: systemic Epstein-Barr virus-positive T-cell lymphoma …

抄録 移植後シクロホスファミド (PTCY) は, もともとは HLA 半合致移植の GVHD
予防薬として開発されたが, 最近では HLA 適合移植においても試みられている. HLA 半合致移植と …